Candriam SCA’s Neurocrine Biosciences NBIX Stock Holding History

Candriam SCA’s Portfolio NBIX Stock Details NBIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$37.5M	Sell	298,551 -32,289	-10%	-$4.06M	0.22%	98
2025 Q1	$36.6M	Buy	330,840 +26,868	+9%	+$2.97M	0.23%	96
2024 Q4	$41.5M	Sell	303,972 -179,269	-37%	-$24.5M	0.24%	87
2024 Q3	$55.7M	Buy	483,241 +17,774	+4%	+$2.05M	0.32%	66
2024 Q2	$64.1M	Buy	465,467 +149,783	+47%	+$20.6M	0.39%	56
2024 Q1	$43.5M	Sell	315,684 -54,215	-15%	-$7.48M	0.28%	80
2023 Q4	$48.7M	Sell	369,899 -7,339	-2%	-$967K	0.34%	70
2023 Q3	$42.4M	Sell	377,238 -63,178	-14%	-$7.11M	0.3%	72
2023 Q2	$41.5M	Buy	440,416 +23,236	+6%	+$2.19M	0.3%	78
2023 Q1	$38.9M	Buy	417,180 +148,008	+55%	+$13.8M	0.27%	89
2022 Q4	$32.1M	Sell	269,172 -2,309	-0.9%	-$276K	0.22%	110
2022 Q3	$28.8M	Sell	271,481 -59,448	-18%	-$6.31M	0.2%	110
2022 Q2	$32.3M	Buy	330,929 +30,722	+10%	+$2.99M	0.27%	93
2022 Q1	$28.1M	Sell	300,207 -9,706	-3%	-$910K	0.19%	122
2021 Q4	$26.4M	Buy	309,913 +228,400	+280%	+$19.5M	0.17%	141
2021 Q3	$7.82M	Buy	81,513 +20	+0%	+$1.92K	0.05%	318
2021 Q2	$7.93M	Sell	81,493 -80,376	-50%	-$7.82M	0.05%	320
2021 Q1	$15.9M	Hold	161,869	–	–	0.13%	176
2020 Q4	$16.6M	Buy	161,869 +5,587	+4%	+$573K	0.13%	178
2020 Q3	$15M	Hold	156,282	–	–	0.14%	171
2020 Q2	$19.1M	Sell	156,282 -30,484	-16%	-$3.72M	0.2%	127
2020 Q1	$19.6M	Hold	186,766	–	–	0.22%	103
2019 Q4	$20.1M	Sell	186,766 -17,903	-9%	-$1.92M	0.22%	103
2019 Q3	$18.4M	Sell	204,669 -63,000	-24%	-$5.68M	0.24%	84
2019 Q2	$22.5M	Sell	267,669 -25,000	-9%	-$2.1M	0.28%	75
2019 Q1	$25.8M	Buy	292,669 +64,600	+28%	+$5.69M	0.33%	62
2018 Q4	$16.3M	Buy	228,069 +78,000	+52%	+$5.57M	0.25%	89
2018 Q3	$18.5M	Buy	150,069 +69,969	+87%	+$8.6M	0.25%	99
2018 Q2	$7.87M	Buy	80,100 +15,100	+23%	+$1.48M	0.12%	207
2018 Q1	$5.39M	Sell	65,000 -35,000	-35%	-$2.9M	0.09%	269
2017 Q4	$7.76M	Sell	100,000 -292,000	-74%	-$22.7M	0.13%	192
2017 Q3	$24M	Sell	392,000 -69,000	-15%	-$4.23M	0.42%	55
2017 Q2	$21.2M	Buy	461,000 +214,000	+87%	+$9.84M	0.4%	57
2017 Q1	$10.7M	Buy	247,000 +78,000	+46%	+$3.38M	0.21%	138
2016 Q4	$6.54M	Buy	169,000 +46,000	+37%	+$1.78M	0.15%	168
2016 Q3	$6.23M	Buy	123,000 +6,700	+6%	+$339K	0.15%	164
2016 Q2	$5.29M	Sell	116,300 -2,700	-2%	-$123K	0.14%	171
2016 Q1	$4.68M	Buy	119,000 +7,000	+6%	+$275K	0.12%	207
2015 Q4	$6.34M	Buy	112,000 +21,000	+23%	+$1.19M	0.17%	144
2015 Q3	$3.62M	Sell	91,000 -14,000	-13%	-$557K	0.09%	249
2015 Q2	$5.02M	Sell	105,000 -50,000	-32%	-$2.39M	0.1%	239
2015 Q1	$6.16M	Sell	155,000 -55,000	-26%	-$2.18M	0.12%	216
2014 Q4	$4.69M	Buy	+210,000	New	+$4.69M	0.1%	242